Medpace Holdings, Inc. Common Stock earnings per share and revenue
On Feb 09, 2026, MEDP reported earnings of 4.67 USD per share (EPS) for Q4 25, beating the estimate of 4.26 USD, resulting in a 9.56% surprise. Revenue reached 708.45 million, compared to an expected 703.19 million, with a 0.75% difference. The market reacted with a -15.90% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 10 analysts forecast an EPS of 3.96 USD, with revenue projected to reach 711.93 million USD, implying an decrease of -15.20% EPS, and increase of 0.49% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
SBC Medical Group Holdings Incorporated Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
$0.12
Actual
$0.14
Surprise
+15.51%
OSR Holdings, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.16
Surprise
-56.86%
Synergy CHC Corp. Common Stock
Report Date
Apr 01, 2026 For Q4 25
Estimate
$0.01
Actual
-$0.72
Surprise
-7158.82%
Co-Diagnostics, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$3.67
Actual
-$3.64
Surprise
+0.87%
FAQ
What were Medpace Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Medpace Holdings, Inc. Common Stock reported EPS of $4.67, beating estimates by 9.56%, and revenue of $708.45M, 0.75% above expectations.
How did the market react to Medpace Holdings, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -15.9%, changed from $530.35 before the earnings release to $446.05 the day after.
When is Medpace Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for Apr 22, 2026.
What are the forecasts for Medpace Holdings, Inc. Common Stock's next earnings report?
Based on 10
analysts, Medpace Holdings, Inc. Common Stock is expected to report EPS of $3.96 and revenue of $711.93M for Q1 2026.